The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
10 January, 2013
While much of the recent discussion around healthcare emphasizes that the pharmaceutical industry is under pressure from the high costs of bringing a drug to market and the regulatory hurdles, we tend to forget that other industries have faced challenges too, changed and survived. There are thousands of diseases with no treatments, representing millions of patients who have no treatment. At the beginning of the 21st century our pharmaceutical business models are urgently in need of disruption to address this unmet need. We are seeing that this may come from an unlikely source, the patients and the disease foundations they support.
09 January, 2013